KAUST-developed biomedical microgravity experiments, SSA-1 and SSA-2, were launched to the International Space Station via SpaceX CR35. The project, involving KAUST, the Saudi Space Agency's BioGravity Program, Axiom Space, and the National Stem Cell Foundation, aims to study brain cells in microgravity to advance neurodegenerative disease research. This environment accelerates conditions mimicking health challenges on Earth, providing insights into diseases like Alzheimer’s and multiple sclerosis. Why it matters: This initiative could significantly accelerate drug discovery for neurodegenerative diseases and develops specialized local infrastructure and human capital in biomedical microgravity research for Saudi Arabia.
MBZUAI valedictorian Salma Hassan developed a multimodal graph learning approach for early dementia diagnosis and prognosis. Her master's thesis focused on differential diagnosis to identify specific dementia subtypes and predicting cognitive decline in preclinical patients. The AI model leverages brain imaging, genetics, and clinical records to improve diagnostic accuracy. Why it matters: This research can improve early detection and resource allocation for dementia management, especially in developing countries.
A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.
Dr. Yves Agid from the ICM Paris Institute of Translational Neuroscience lectured at KAUST's 2018 Winter Enrichment Program about the role of glial cells in brain function and behavior. He highlighted that glial cells, often overlooked in research, are crucial for neural synchronization and overall intelligence. Dysfunction of glial cells can induce pathologies like Alzheimer's and Parkinson's disease. Why it matters: The lecture underscored the importance of studying glial cells in addition to neurons for understanding and treating neurodegenerative disorders, which could influence future research directions at KAUST and in the region.
MBZUAI researchers developed ClinGRAD, a multimodal graph neural network that analyzes genomic data, MRI scans, and clinical information to classify dementia types (Alzheimer's, vascular, etc.). The system addresses the challenge of high misdiagnosis rates (up to 30%) in dementia, where incorrect diagnoses can significantly impact patient life expectancy. ClinGRAD aims to be an interpretable AI system, providing explainability to clinicians. Why it matters: Accurate and early diagnosis of dementia subtypes is crucial for slowing disease progression and improving patient care in the region, where the prevalence of dementia is expected to rise significantly.
KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.
KAUST hosted the Nature Conferences: Brain Energy Metabolism in Health and Disease, convening experts to discuss brain energy use and its impact on function and disease. Researchers from KAUST and global institutions shared insights on metabolic interactions among brain cells and the brain's role in whole-body energy regulation. KAUST's President Sir Edward Byrne emphasized brain health as essential for the cognitive economy, aligning with Saudi Arabia’s Vision 2030. Why it matters: The conference highlights KAUST's growing role in global neuroscience research and its commitment to addressing critical health challenges through international collaboration.